Responsible Investment Policy and Integration of Sustainability Risks
As an investor in the healthcare sector, the integration of Environmental, Social, and Governance (ESG) factors into our investment processes is key for Vivalto Partners. We are convinced that this approach will ensure our success in supporting the sustainable growth of ambitious and innovative companies and will help them develop solutions to the healthcare challenges of tomorrow. To this end, we integrate sustainability risks into every stage of our investment decisions. Our specialization in the unlisted healthcare sector determines the nature of these risks and how we address them: they are primarily risks related to people, quality of care, and governance.
This policy applies to all the funds we manage. It is published in accordance with Article 3 of Regulation (EU) 2019/2088.
At Vivalto Partners, we are convinced that taking ESG issues into account is a hallmark of a company with robust operational processes and will justify a higher valuation at the time of exit.
A sustainability risk is an environmental, social, or governance event or situation that, if it occurs, could significantly affect the value of an investment.
It should not be confused with the concept of negative impact: sustainability risk concerns the effect of the world on our investments, while negative impact concerns the effect of our investments on the world. We address both, with the latter being the subject of a separate disclosure.
Given our sector, the risks we prioritize are:
Before investing. We first verify that the target company is not engaged in any activities on our exclusion list. We then systematically assess its ESG risks using a checklist that covers material issues and incorporates an analysis of climate risks and opportunities. When high risks are identified, ESG due diligence may be conducted by an independent third party. The findings are included in the information memorandum and presented to our investment committee before any decision is made. A contentious issue that cannot be resolved may lead us to forgo the investment.
During the holding period. We work with each company to define an ESG roadmap covering, at a minimum, ethics and governance, human resources, and the environment. Each year, we collect the company’s ESG data—including the 14 mandatory indicators and the 2 optional indicators on major adverse impacts—on a dedicated platform; an independent consultant verifies the consistency of this data during an interview with each company. ESG topics are included on the agenda of a governance body at least once a year. When a risk materializes, mitigation measures are added to the roadmap, and their implementation is monitored.
At exit. We assess the company’s ESG progress and document this assessment in a dedicated report.
We do not invest in companies operating in a country subject to international sanctions, as identified by the EU Sanctions Map, or in a country with high ESG risks, as identified by the Sustainalytics Country Risk Rating.
We also do not invest in the sectors listed in our ESG Policy.
Our portfolios have no exposure to fossil fuels, biodiversity-sensitive areas, or controversial weapons. We therefore do not anticipate that sustainability risks will have a significant impact on the performance of our funds as a whole.
This conclusion does not mean that no risks could materialize within an individual company. We review it annually in light of our data collection efforts.
Sustainability Risk Integration Policy
Article 3 SFDR
Statement on Significant Adverse Impacts
Article 4 SFDR
Sustainability Information for Our Funds
Article 10 SFDR
Download our 2025 ESG report
Article 29LEC